Preterm labor nursing: complete reference guide for nursing students

Preterm labor — the onset of regular contractions with cervical change before 37+0 weeks gestation — affects approximately 1 in 10 births in the United States and is the leading cause of neonatal morbidity and mortality worldwide. For nurses working in labor and delivery, antepartum, or maternal-fetal medicine settings, recognizing preterm labor early and executing the correct interventions in the right sequence can meaningfully change neonatal outcomes. The priorities are clear: confirm the diagnosis, administer antenatal corticosteroids to mature fetal lungs, suppress contractions long enough for steroids to work, and prepare both the family and the NICU team. This reference covers the complete clinical picture — from diagnosis criteria and risk stratification through tocolytic management, magnesium monitoring, PPROM protocols, and the NCLEX concepts tested most frequently.

Quick reference: preterm labor at a glance

Definition and classification

Preterm birth is defined by the World Health Organization and ACOG as delivery before 37 completed weeks of gestation (37+0 weeks). The sub-classification by gestational age matters clinically because it shapes resuscitation decisions, NICU resource allocation, and parental counseling:

• Extreme preterm (less than 28+0 weeks): the highest-acuity group. Survival rates have improved substantially with modern NICU care, but survivors face significant risks of chronic lung disease, neurodevelopmental disability, retinopathy of prematurity, and necrotizing enterocolitis. A neonatal resuscitation team should be present at delivery.
• Very preterm (28+0 to 31+6 weeks): substantial risk; antenatal corticosteroids, magnesium sulfate for neuroprotection, and NICU-level care are all indicated.
• Moderate to early preterm (32+0 to 33+6 weeks): corticosteroids remain strongly indicated; tocolysis and neuroprotection should be considered.
• Late preterm (34+0 to 36+6 weeks): the largest sub-category (approximately 70% of preterm births). Though often perceived as “almost term,” late preterm infants have meaningfully higher rates of respiratory distress, hypoglycemia, feeding difficulties, and NICU admission than term infants. Antenatal corticosteroids are now recommended for this group if not previously administered (ACOG Committee Opinion 713, 2017, reaffirmed 2021).

The diagnosis of preterm labor requires two criteria to be present simultaneously: (1) regular uterine contractions occurring at least every 10 minutes and (2) documented cervical change — specifically, dilation of at least 2 cm or effacement of at least 80%. Contractions alone without cervical change do not confirm preterm labor.

Ruling out false labor: fFN and cervical length

Two tools help stratify risk before committing to inpatient treatment:

Fetal fibronectin (fFN) is a glycoprotein found at the interface between the chorion and the decidua. Normally present before 22 weeks and near term, a positive fFN between 22+0 and 34+6 weeks suggests disruption of the fetal-maternal interface. A negative result is the clinically useful finding — negative fFN carries an NPV of approximately 95–99%, meaning delivery within the next 7–14 days is very unlikely. This allows clinicians to avoid unnecessary tocolytic therapy and hospitalization in low-risk patients. Specimen must be collected before a digital cervical exam and before lubricant is applied; contamination with blood, amniotic fluid, or sexual activity within 24 hours can give a false positive.

Cervical length by transvaginal ultrasound provides independent risk stratification. A cervical length below 25 mm at 20–24 weeks is associated with significantly increased preterm birth risk. In symptomatic patients, cervical length above 30 mm combined with a negative fFN makes delivery within 7 days unlikely. A short cervix in an asymptomatic patient between 16 and 24 weeks may prompt progesterone supplementation (vaginal progesterone or 17-OHPC) — a prevention strategy rather than a treatment strategy.

Risk factors

Prior spontaneous preterm birth is the single strongest risk factor for recurrent preterm birth, conferring a 15–30% recurrence risk. Other major risk factors include:

• Multiple gestation (twins, triplets): uterine overdistension and cervical incompetence increase risk substantially
• Cervical insufficiency / short cervix: previous LEEP or cone biopsy, prior cervical dilation without contractions
• Intrauterine infection / chorioamnionitis: ascending bacteria from the lower genital tract trigger prostaglandin release and cervical ripening
• Preterm premature rupture of membranes (PPROM): membrane rupture before 37 weeks without labor onset; responsible for approximately one-third of preterm births
• Uterine anomalies: septate uterus, bicornuate uterus, large fibroids distorting the cavity
• Substance use: cocaine, methamphetamine, and tobacco use are all independently associated with preterm birth and fetal growth restriction
• Socioeconomic and demographic factors: Black women in the United States experience preterm birth at roughly 1.5× the rate of white women (CDC NVSS data), a disparity attributable to chronic stress, structural inequality, and differential access to prenatal care — not biological predisposition
• Gestational diabetes and preeclampsia: both conditions increase preterm birth risk; refer to the gestational diabetes nursing reference and the preeclampsia nursing reference for management of these comorbidities

Nursing assessment

When a patient presents with possible preterm labor, the nursing assessment should proceed systematically:

1. Uterine activity monitoring: Place the patient on continuous external electronic fetal monitoring (EFM). Assess contraction frequency (minutes between starts), duration (seconds), and intensity (palpation). Establish a baseline fetal heart rate and assess for category II or III FHR patterns that might indicate fetal compromise.

2. Cervical assessment: Perform a sterile vaginal exam if membranes are intact (or use sterile speculum exam if rupture is suspected) to document dilation (0–10 cm), effacement (0–100%), station (−5 to +5), consistency, and position. Document serially to identify change. Note: if PPROM is suspected, avoid digital exam — use sterile speculum only.

3. Rule out PPROM: Assess for pooling of fluid in the posterior vaginal vault on speculum exam. Confirm with:

• Nitrazine (pH) test: amniotic fluid is alkaline (pH 7.1–7.3); a positive Nitrazine result turns paper blue. False positives occur with blood, semen, or vaginosis.
• Ferning: amniotic fluid on a dry slide forms a fern-like crystallization pattern under microscopy.
• AmniSure (PAMG-1) or ROM Plus tests: immunoassay-based; higher sensitivity and specificity than Nitrazine or ferning.

4. Vital signs and infection assessment: Obtain maternal temperature, heart rate, blood pressure, and respiratory rate. Fever above 38°C in a patient with preterm labor or PPROM raises concern for chorioamnionitis and requires further evaluation (fundal tenderness, maternal and fetal tachycardia, foul-smelling discharge, elevated WBC).

5. Hydration assessment: Obtain urine specific gravity or assess clinical signs of dehydration. Dehydration triggers ADH release and can precipitate or worsen uterine contractions. IV fluid hydration (1 L normal saline over 30–60 min) is a reasonable initial intervention, though evidence that hydration stops true preterm labor is limited. It is still standard practice to rule out dehydration as a contributing factor.

6. Laboratory workup (per provider order): CBC with differential, GBS culture (if status unknown), urinalysis and culture (urinary infection is a common preterm labor trigger), fFN collection (before cervical exam), and vaginal/rectal GBS swab.

Medical management and nursing interventions

Antenatal corticosteroids — the priority intervention

Antenatal corticosteroids (ACS) are the single most important intervention in preterm labor. They accelerate fetal lung maturation by stimulating surfactant production and have been shown to reduce the incidence of respiratory distress syndrome (RDS) by approximately 34%, intraventricular hemorrhage (IVH) by 46%, necrotizing enterocolitis (NEC), and neonatal death (ACOG Committee Opinion 713; Roberts et al., Cochrane 2017).

Regimens:

• Betamethasone: 12 mg IM × 2 doses, given 24 hours apart (the standard regimen in the United States)
• Dexamethasone: 6 mg IM × 4 doses, given 12 hours apart (used when betamethasone is unavailable; equivalent efficacy for most outcomes)

Gestational age windows:

• Strongly recommended from 24+0 to 34+6 weeks for patients at risk of delivery within 7 days
• Recommended from 34+0 to 36+6 weeks (late preterm window) if patient has not previously received a completed ACS course and is at risk of delivery within 7 days (ACOG 2017)
• Consideration below 24 weeks is made on an individualized basis (viability threshold varies by institution)

Timing of benefit: Full benefit occurs when at least 24 hours have elapsed between the first dose and delivery. Partial but meaningful benefit can occur even when less than 24 hours have passed — administering ACS even in rapidly advancing labor is still indicated. A single completed course is the standard; rescue course (one repeat course only) may be considered if ≥7 days have passed since first course and the patient remains at risk at <34 weeks.

Nursing responsibilities: Administer IM (gluteal muscle — rotate sites for second dose), document time of each injection precisely, and educate the patient: “We’re giving you two steroid injections to help mature your baby’s lungs in case delivery happens soon. The full benefit takes about 24 hours, so every hour we can buy matters.”

Tocolytics — suppressing contractions

Tocolytic therapy does not prevent preterm birth or improve long-term neonatal outcomes when used indefinitely — the goal is solely to suppress contractions for 48–72 hours to allow full steroid effect and, if needed, maternal transport to a higher-level facility. Tocolysis beyond 48 hours is not supported by evidence (ACOG Practice Bulletin 171, 2016, reaffirmed 2021).

Magnesium sulfate nursing monitoring in depth: Because MgSO4 is used in preterm labor both as a tocolytic and for fetal neuroprotection (see below), and because toxicity can be life-threatening, nurses must know the progression of toxicity findings by serum level:

• Therapeutic tocolytic/neuroprotective range: 4–7 mEq/L (some protocols target 4–8 mEq/L)
• Loss of patellar deep tendon reflexes (DTRs): typically around 7–10 mEq/L — this is the earliest clinical sign of toxicity; check DTRs every 1–2 hours during infusion
• Respiratory depression (RR <12/min): typically around 10–13 mEq/L — maintain RR ≥12/min as a hard stop criterion
• Respiratory arrest: above 15 mEq/L
• Cardiac arrest: above 15–20 mEq/L

Urine output must be maintained at ≥30 mL/hr because magnesium is renally cleared — oliguria rapidly raises serum levels into the toxic range. If urine output falls below 30 mL/hr, hold the infusion and notify the provider immediately. The antidote — calcium gluconate 1 g (10 mL of 10% solution) IV push over 3 minutes — must be drawn up and at the bedside for every patient on a MgSO4 infusion. See the electrolyte imbalances nursing reference for additional magnesium physiology.

Magnesium sulfate for fetal neuroprotection

Independent of its tocolytic properties, magnesium sulfate administered before anticipated delivery at less than 32 weeks gestation significantly reduces the incidence of cerebral palsy in surviving infants — the largest benefit seen in the MFMU Network trial (Rouse et al., NEJM 2008). This is a distinct indication from tocolysis, with its own protocol: the drug is given when preterm delivery at <32 weeks appears imminent (cervical dilation ≥4 cm with contractions, or in cases of indicated preterm birth such as severe preeclampsia). The infusion protocol is typically the same as for tocolysis (4–6 g IV loading, 1–2 g/hr maintenance), and nursing monitoring is identical. The two uses — tocolysis and neuroprotection — may overlap in the same patient.

GBS prophylaxis

Group B Streptococcus colonization in the maternal genital tract at the time of preterm delivery carries significant neonatal sepsis risk. If GBS status is unknown or positive, administer intrapartum antibiotic prophylaxis:

• Penicillin G 5 million units IV × 1 loading dose, then 2.5–3 million units IV every 4 hours until delivery (first-line)
• Ampicillin 2 g IV × 1, then 1 g IV every 4 hours (acceptable alternative)
• Penicillin allergy (low anaphylaxis risk): cefazolin 2 g IV × 1, then 1 g IV every 8 hours
• Penicillin allergy (high anaphylaxis risk): vancomycin or clindamycin based on sensitivity testing

PPROM-specific management

When preterm labor is complicated by premature rupture of membranes, the clinical priorities shift. The patient is now at risk for ascending infection (chorioamnionitis), umbilical cord prolapse, and fetal malpresentation. Key nursing actions:

1. Confirm rupture: Sterile speculum exam only — no digital exam (digital exam dramatically increases infection risk by introducing vaginal flora into the cervical os). Check for pooling, perform Nitrazine and ferning tests, or use AmniSure.

2. Latency antibiotics: Ampicillin 2 g IV every 6 hours × 48 hours, followed by amoxicillin 250 mg oral every 8 hours × 5 days — given concurrently with erythromycin 250 mg IV every 6 hours × 48 hours, then erythromycin 333 mg oral every 8 hours × 5 days (the NICHD MFMU “7-day course”). This latency regimen prolongs the rupture-to-delivery interval, reduces maternal and neonatal infection, and improves neonatal outcomes. Azithromycin has replaced erythromycin at many institutions.

3. Surveillance for chorioamnionitis: Monitor maternal temperature every 2–4 hours, fetal heart rate baseline (fetal tachycardia above 160 bpm is an early sign), maternal heart rate (tachycardia), and fundal tenderness (elicited with gentle palpation). Foul or offensive amniotic fluid odor is a late sign. Maternal WBC >15,000/mm³ with a left shift supports the diagnosis. When chorioamnionitis is diagnosed, delivery is indicated regardless of gestational age — infection is not managed expectantly.

4. Activity and surveillance: Bed rest, frequent vital signs, daily fetal kick counts, periodic biophysical profiles or non-stress tests per protocol, and monitoring of amniotic fluid index.

Clinical applications

In labor and delivery

When a patient arrives at triage with uterine contractions at 29 weeks, the nursing priority sequence is: establish IV access, place EFM, collect fFN before any vaginal exam, perform sterile speculum exam first if rupture is suspected, and notify the provider. Once the diagnosis of preterm labor is confirmed, corticosteroids should be ordered and administered before the patient is transferred to antepartum — the steroid clock starts the moment the first injection is given.

For patients already admitted on MgSO4, the most important nursing task is hourly reflex and respiratory checks. A nurse who misses early DTR loss before the provider is notified is the critical failure point in MgSO4 toxicity events. Never leave these assessments to “as needed” status — build them into the care rhythm as a timed intervention.

Patient education priorities

Patients sent home after an episode of preterm contractions that resolved need to know the warning signs requiring immediate return: regular contractions every 10 minutes or more frequently (even if painless), pelvic pressure or a feeling that the baby is pushing down, low dull back pain (especially rhythmic), watery or bloody vaginal discharge, or the sensation that something has “popped.” Pelvic rest and activity restriction are commonly prescribed; if prescribed, explain specifically what pelvic rest means (no intercourse, no digital vaginal exams, no tampon use). Hydration — 8–10 glasses of water per day — does not prevent preterm labor but dehydration can worsen contraction frequency. Smoking cessation counseling should occur at every encounter given the established association between tobacco and preterm birth.

Coordination with the NICU team

When delivery before 34 weeks appears imminent, involve the NICU team early. A neonatal resuscitation team should be present in the delivery room for any birth at or below 32 weeks. Parents benefit from a pre-delivery consultation with the neonatology team — hearing survival statistics, likely length of NICU stay, and what the first hours look like reduces parental anxiety and supports informed consent for resuscitation decisions at the margin of viability. See the obstetric nursing reference for the broader context of high-risk obstetric nursing care.

Common confusions

Preterm labor vs. preterm PROM: Preterm labor has intact membranes with contractions and cervical change. PPROM has ruptured membranes before the onset of labor — labor may follow within hours or days, or may be delayed for weeks. Management differs: the initial exam differs (speculum only in PPROM), antibiotics are mandatory in PPROM, and the infection surveillance approach is different. On NCLEX, if you see “gush of fluid” or “pooling” — think PPROM first and avoid the digital exam.

Tocolysis vs. cervical ripening: Tocolytics suppress contractions to delay delivery. Cervical ripening agents (misoprostol, dinoprostone, mechanical dilation) promote delivery. These are never used together. Indomethacin is an NSAID used as a tocolytic; it shares a drug class with misoprostol only superficially — their clinical roles are completely opposite.

Nifedipine vs. magnesium: Both suppress contractions by different mechanisms (CCB vs. CNS depression/calcium antagonism). The key clinical rule: do not combine them. The risk is compounded neuromuscular blockade and hypotension. On NCLEX, if a patient is already on magnesium sulfate, adding nifedipine requires a provider order review — it is flagged as a potential interaction.

Betamethasone for fetal lungs vs. corticosteroids for maternal illness: Students sometimes confuse antenatal corticosteroids (given to the mother to benefit the fetus) with systemic steroids prescribed for maternal conditions like asthma. These are different indications. Betamethasone administered IM for fetal lung maturation is a time-sensitive obstetric intervention — it should never be delayed waiting for a second opinion.

NCLEX high-yield points

1. Betamethasone is always the priority. Before tocolytics, before antibiotics (except GBS prophylaxis if delivery is imminent), before most other interventions — administer antenatal corticosteroids. The window of benefit is 24–34+6 weeks (and up to 36+6 for late preterm).

2. MgSO4 antidote = calcium gluconate 1 g IV. It must be at the bedside. If asked what to do first when you see signs of magnesium toxicity, the answer is: stop the infusion AND have calcium gluconate ready.

3. Patellar DTRs are the first reflex to disappear in MgSO4 toxicity. Check them every 1–2 hours. If the reflex is absent, stop the infusion and notify the provider immediately.

4. Minimum urine output = 30 mL/hr on MgSO4. Magnesium is renally cleared. Below 30 mL/hr, the drug accumulates and serum levels rise toward toxic range.

5. Indomethacin is contraindicated after 32 weeks. After 32 weeks, the fetal ductus arteriosus is sensitive to prostaglandin inhibition and can close prematurely, causing pulmonary hypertension. Limit use to <32 weeks for no more than 48 hours.

6. Do not combine nifedipine with magnesium sulfate. This combination risks neuromuscular blockade and significant maternal hypotension. It appears regularly as a drug interaction question.

7. Terbutaline: monitor maternal HR and blood glucose. Beta-2 stimulation causes tachycardia and promotes glycogenolysis (hyperglycemia). Also watch for hypokalemia. Terbutaline carries an FDA black box warning against use for ≥48 hours or as an outpatient tocolytic.

8. Negative fFN = high reassurance. A negative fetal fibronectin result makes delivery within 7–14 days very unlikely (NPV 95–99%). It is used to rule out true preterm labor and avoid unnecessary hospitalization or tocolytic treatment.

9. GBS prophylaxis is indicated when GBS status is unknown or positive and preterm delivery is anticipated. Penicillin G is first-line. Begin infusion as early as possible — the goal is ≥4 hours of antibiotics before delivery.

10. Chorioamnionitis signs: fever, uterine tenderness, fetal tachycardia, maternal tachycardia, foul amniotic fluid odor. When chorioamnionitis is diagnosed, delivery is the treatment — regardless of gestational age. Tocolytics are contraindicated in the setting of active intra-amniotic infection.

Related references

For a complete picture of high-risk obstetric nursing, this article works alongside several companion references on this site. The obstetric nursing reference covers the full scope of antepartum and intrapartum care. The postpartum hemorrhage nursing reference addresses the immediate postpartum period, which can follow preterm delivery after tocolysis fails. The preeclampsia nursing reference covers an overlapping patient population — preeclampsia is a common reason for indicated preterm delivery. The gestational diabetes nursing reference covers another condition linked to increased preterm risk. For interpreting the laboratory values relevant to magnesium monitoring, infection workup, and coagulation status in these patients, see the nursing lab values cheat sheet.

Clinical sources

• ACOG Practice Bulletin 171 (2016, reaffirmed 2021): Management of Preterm Labor
• ACOG Practice Bulletin 172 (2016, reaffirmed 2021): Premature Rupture of Membranes
• ACOG Committee Opinion 713 (2017, reaffirmed 2021): Antenatal Corticosteroid Therapy for Fetal Maturation
• Rouse DJ, Hirtz DG, Thom E, et al. A randomized, controlled trial of magnesium sulfate for the prevention of cerebral palsy. New England Journal of Medicine. 2008;359(9):895–905.
• Roberts D, Brown J, Medley N, Dalziel SR. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database of Systematic Reviews. 2017;(3):CD004454.
• Mercer BM, Miodovnik M, Thurnau GR, et al. Antibiotic therapy for reduction of infant morbidity after preterm premature rupture of the membranes. NICHD MFMU Network. JAMA. 1997;278(12):989–995.
• Errol R. Norwitz and Julian N. Robinson. “Preterm Labor.” StatPearls. NCBI Bookshelf, updated 2023.
• Martin JA, Hamilton BE, Osterman MJK. Births in the United States, 2022. NCHS Data Brief No. 477. CDC National Center for Health Statistics, 2023.